Quick Links

Cancer

Diabetes drug found not to cause pancreatic cancer

By Tod Hoffman, Lady Davis Institute for Medical Research

The use of incretin-based drugs is not associated with an increased risk of pancreatic cancer in patients with type 2 diabetes, according to a study published in the latest issue of the British Medical Journal (BMJ).

The research was conducted by the Canadian Network for Observational Drug Effect Studies (CNODES), which used the health records of almost 1 million patients with types 2 diabetes.

Published: 22Feb2016

Investment In a Quebec Public-Private Partnership to Support the Use of Personalized Medicine Solutions in the Treatment of Cancer Patients

The Government of Québec announced today a $10 million investment in the Personalized Medicine Partnership for Cancer (PMPC). This public-private partnership will be focused on establishing an integrated approach for the development and implementation of clinical biomarkers and other personalized healthcare solutions to improve the outcome and cost-efficiency of healthcare services provided to cancer patients in the province of Québec and abroad.

Published: 21Feb2013